| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |